NanJing Pharmaceutical Co Ltd
SSE:600713
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
NanJing Pharmaceutical Co Ltd
NanJing Pharmaceutical Co Ltd
PP&E Net
NanJing Pharmaceutical Co Ltd
PP&E Net Peer Comparison
1099
601607
600998
000963
Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors
| Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
NanJing Pharmaceutical Co Ltd
SSE:600713
|
PP&E Net
¥1.5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
PP&E Net
¥19.7B
|
CAGR 3-Years
1%
|
CAGR 5-Years
12%
|
CAGR 10-Years
12%
|
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
PP&E Net
¥18.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
9%
|
CAGR 10-Years
14%
|
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
PP&E Net
¥9B
|
CAGR 3-Years
4%
|
CAGR 5-Years
8%
|
CAGR 10-Years
14%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
PP&E Net
¥828.9m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
6%
|
CAGR 10-Years
7%
|
|
|
Huadong Medicine Co Ltd
SZSE:000963
|
PP&E Net
¥5.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
14%
|
CAGR 10-Years
16%
|
See Also
What is NanJing Pharmaceutical Co Ltd's PP&E Net?
PP&E Net
1.5B
CNY
Based on the financial report for Mar 31, 2024, NanJing Pharmaceutical Co Ltd's PP&E Net amounts to 1.5B CNY.
What is NanJing Pharmaceutical Co Ltd's PP&E Net growth rate?
PP&E Net CAGR 10Y
8%
Over the last year, the PP&E Net growth was 0%. The average annual PP&E Net growth rates for NanJing Pharmaceutical Co Ltd have been -2% over the past three years , 7% over the past five years , and 8% over the past ten years .
You don't have any saved screeners yet
